Clinical Trials Information System (CTIS): Walk-in clinic - May 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 15 May 2024, 16:00 (CEST) to 15 May 2024, 17:00 (CEST)

Submitted by Anonymous (not verified) on 18 April 2024 - 8:59

Clinical Trials Information System (CTIS): Walk-in clinic - May 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 15 May 2024, 16:00 (CEST) to 15 May 2024, 17:00 (CEST)

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation: 22/11/2018, Revision: 17, Status: Authorised

Submitted by Anonymous (not verified) on 18 April 2024 - 8:36

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Date of authorisation: 22/11/2018, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Xolair, omalizumab, Date of authorisation: 25/10/2005, Revision: 50, Status: Authorised

Submitted by Anonymous (not verified) on 17 April 2024 - 15:03

Human medicines European public assessment report (EPAR): Xolair, omalizumab, Date of authorisation: 25/10/2005, Revision: 50, Status: Authorised

Human medicines European public assessment report (EPAR): Talzenna, talazoparib, Date of authorisation: 20/06/2019, Revision: 8, Status: Authorised

Submitted by Anonymous (not verified) on 17 April 2024 - 14:24

Human medicines European public assessment report (EPAR): Talzenna, talazoparib, Date of authorisation: 20/06/2019, Revision: 8, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More